Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02082405Phase 2Withdrawn
Bortezomib, Dexamethasone, and Cyclophosphamide in Treating Older Patients With Multiple Myeloma
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Case Comprehensive Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ann Mohrbacher, MD

University of Southern California

Moderately Similar
4 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Craig Hofmeister, MD

Ohio State University

Moderately Similar
4 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Similarity Score30%

Robert Kyle

Eastern Cooperative Oncology Group

Moderately Similar
1 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Zaid Al-Kadhimi

Barbara Ann Karmanos Cancer Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Alexander Stewart

Mayo Clinic

Moderately Similar
1 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Angela Dispenzieri

Mayo Clinic

Moderately Similar
3 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Ryotaro Nakamura

City of Hope Medical Center

Moderately Similar
10 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Mohamad A. Hussein, MD

The Cleveland Clinic

Moderately Similar
8 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Shaji Kumar, M.D.

Mayo Clinic

Moderately Similar
7 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Vinod Pullarkat, MD

City of Hope Medical Center

Moderately Similar
1 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02082405Phase 2PrincipalInvestigator

Bortezomib, Dexamethasone, and Cyclophosphamide in Treating Older Patients With Multiple Myeloma

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Withdrawn

All 1 trials loaded